Portola Pharmaceuticals to Announce First Quarter 2017 Financial Results and Host Conference Call on Monday, May 8
01 Mai 2017 - 2:00PM
Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) announced today that
it will host a webcast and conference call to discuss the Company's
financial results for the quarter ended March 31, 2017, and
provide a general business overview on Monday, May 8, 2017
at 4:30 p.m. ET (1:30 p.m. PT).
Conference Call Details The live conference
call on Monday, May 8, 2017, at 4:30 p.m. Eastern Time,
can be accessed by phone by calling (844) 452-6828 from the
United States and Canada or 1-765-507-2588
internationally and using the passcode 8594347. The webcast can be
accessed live on the Investor Relations section of the Company's
website at http://investors.portola.com. It will be archived
for 30 days following the call.
About Portola Pharmaceuticals, Inc.
Portola Pharmaceuticals is a biopharmaceutical company
developing product candidates that could significantly advance the
fields of thrombosis and other hematologic diseases. The Company is
advancing three programs, including betrixaban, an oral, once-daily
Factor Xa inhibitor; AndexXaTM (andexanet alfa), a recombinant
protein designed to reverse the anticoagulant effect in patients
treated with an oral or injectable Factor Xa inhibitor; and
cerdulatinib, a Syk/JAK inhibitor in development to treat
hematologic cancers. Portola's partnered program is focused on
developing selective Syk inhibitors for inflammatory conditions.
For more information, visit www.portola.com and follow the
Company on Twitter @Portola_Pharma.
Investor Contact:
Ana Kapor
Portola Pharmaceuticals
ir@portola.com
Media Contact:
Julie Normart
Pure Communications
jnormart@purecommunications.com
415.946.1087
Portola Pharmaceuticals (NASDAQ:PTLA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Portola Pharmaceuticals (NASDAQ:PTLA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Portola Pharmaceuticals Inc (NASDAQ): 0 recent articles
Plus d'articles sur